• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
              Advocacy & Research for Unlimited Lifespans

- - - - -

Anti-aging Drugs: From Basic Research to Clinical Practice

anti-aging longevity life-extension public health policy basic research clinical practice advocacy activism

  • Please log in to reply
No replies to this topic
⌛⇒ MITOMOUSE has been fully funded!

#1 ilia

  • Guest, Moderator
  • 607 posts
  • 255
  • Location:Israel

Posted 10 February 2017 - 08:59 AM

A new book has been published entitled: “Anti-aging Drugs: From Basic Research to Clinical Practice”, by the Royal Society of Chemistry, including the chapters on “Anti-Aging Drugs: Where are We and Where are We Going?” by Alexander Vaiserman (the book editor), “Antidiabetic Biguanides as Anti-Aging Drugs” by Vladimir Anisimov, “Hormetins as Drugs for Healthy Aging” by Suresh Rattan, “Lifespan-Extending Effect of Resveratrol and Other Phytochemicals” by Kyung-Jin Min, “Human life extension: opportunities, challenges, and implications for public health policy” by Ilia Stambler, and others.


Available at:


Google books


On life-extension and public health policy, see also: Ilia Stambler. Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy. Aging and Disease, 8 (5), 2017. doi: 10.14336/AD.2017.0130 (free and open access)





Thanks for sharing and spreading the word!

Attached Files

  • Informative x 1

Also tagged with one or more of these keywords: anti-aging, longevity, life-extension, public health policy, basic research, clinical practice, advocacy, activism

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users